Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:39 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 530549 | NSE: SHILPAMED

Shilpa Medicare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹174.52Overvalued by 53.46%vs CMP ₹375.00

P/E (41.4) × ROE (4.2%) × BV (₹125.00) × DY (0.13%)

₹150.54Overvalued by 59.86%vs CMP ₹375.00
MoS: -149.1% (Negative)Confidence: 67/100 (Moderate)Models: All 8: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹204.2926%Over (-45.5%)
Graham NumberEarnings₹146.8719%Over (-60.8%)
DCFCash Flow₹138.0013%Over (-63.2%)
Net Asset ValueAssets₹124.718%Over (-66.7%)
EV/EBITDAEnterprise₹189.1911%Over (-49.5%)
Earnings YieldEarnings₹76.708%Over (-79.5%)
ROCE CapitalReturns₹100.148%Over (-73.3%)
Revenue MultipleRevenue₹98.336%Over (-73.8%)
Consensus (8 models)₹150.54100%Overvalued
Key Drivers: ROE 4.2% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 17.1%

*Investments are subject to market risks

Analyst Summary

Shilpa Medicare Ltd operates in the Pharmaceuticals segment, NSE: SHILPAMED | BSE: 530549, current market price is ₹375.00, market cap is 7,328 Cr.. At a glance, stock P/E is 41.4, ROE is 4.21 %, ROCE is 7.82 %, book value is 125, dividend yield is 0.13 %. The latest intrinsic value estimate is ₹150.54, around 59.9% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹1,281 Cr versus the prior period change of 11.8%, while latest net profit is about ₹78 Cr with a prior-period change of 143.8%. This analysis page also carries profit and loss, shareholding pattern, ratio panels, mutual fund holdings data, which improves the depth of the template beyond a thin price-only snapshot. The 52-week range shown on this page is 502/260, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisShilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is invol…

This summary is generated from the stock page data available for Shilpa Medicare Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

57
Shilpa Medicare Ltd scores 57/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health53/100 · Moderate
ROCE 7.8% WeakROE 4.2% WeakD/E 0.48 ModerateInterest Coverage 0.0x RiskyProfitable 4/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changeDII holding up 0.79% MF buyingPromoter decreased by 4.10% Caution
Earnings Quality65/100 · Strong
OPM expanding (14% → 23%) Improving
Quarterly Momentum80/100 · Strong
Revenue (4Q): +15% YoY GrowingProfit (4Q): +72% YoY Strong
Industry Rank25/100 · Weak
P/E 41.4 vs industry 53.8 In-lineROCE 7.8% vs industry 16.4% Below peersROE 4.2% vs industry 15.2% Below peers3Y sales CAGR: 4% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:39 am

Market Cap 7,328 Cr.
Current Price 375
Intrinsic Value₹150.54
High / Low 502/260
Stock P/E41.4
Book Value 125
Dividend Yield0.13 %
ROCE7.82 %
ROE4.21 %
Face Value 1.00
PEG Ratio2.43

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Shilpa Medicare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Shilpa Medicare Ltd 7,328 Cr. 375 502/26041.4 1250.13 %7.82 %4.21 % 1.00
Sanofi India Ltd 7,513 Cr. 3,262 6,718/3,15121.7 3262.30 %57.5 %43.0 % 10.0
Marksans Pharma Ltd 7,615 Cr. 168 271/15521.1 59.30.48 %20.0 %16.8 % 1.00
Procter & Gamble Health Ltd 7,983 Cr. 4,809 6,739/4,72527.2 3732.60 %47.8 %36.4 % 10.0
Blue Jet Healthcare Ltd 6,089 Cr. 351 1,028/32520.7 72.40.34 %39.8 %30.2 % 2.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Shilpa Medicare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 262264260313287292293344319331321370410
Expenses 231227214255222222222258239254231262296
Operating Profit 3137465865707086817791108114
OPM % 12%14%18%19%23%24%24%25%25%23%28%29%28%
Other Income 3222291052-1862-12
Interest 18181823262424261214191611
Depreciation 24262728272727282929293030
Profit before tax -8-439142829374215506461
Tax % -13%90%64%83%67%12%51%51%24%5%5%32%27%
Net Profit -7-81252414183215474445
EPS in Rs -0.38-0.460.070.090.261.410.720.921.620.742.402.252.28

Last Updated: March 3, 2026, 2:50 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 7:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5716147197797897339088991,1411,0461,1461,2811,432
Expenses 4554855666146345856887189409479079651,042
Operating Profit 11612915316515514821918120299239316390
OPM % 20%21%21%21%20%20%24%20%18%9%21%25%27%
Other Income 6551522331790211715-5-22
Interest 4473345224159927660
Depreciation 23212931374244548096108113118
Profit before tax 95108122146137136188195102-3854122190
Tax % 21%33%19%29%25%19%18%25%41%-19%41%36%
Net Profit 75739910410311015514661-313278150
EPS in Rs 5.144.786.736.716.456.889.579.063.49-1.871.844.007.67
Dividend Payout % 5%6%4%4%5%7%6%6%16%0%0%12%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-2.67%35.62%5.05%-0.96%6.80%40.91%-5.81%-58.22%-150.82%203.23%143.75%
Change in YoY Net Profit Growth (%)0.00%38.28%-30.57%-6.01%7.76%34.11%-46.72%-52.41%-92.60%354.05%-59.48%

Shilpa Medicare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:7%
3 Years:4%
TTM:11%
Compounded Profit Growth
10 Years:2%
5 Years:-11%
3 Years:16%
TTM:213%
Stock Price CAGR
10 Years:6%
5 Years:11%
3 Years:29%
1 Year:1%
Return on Equity
10 Years:6%
5 Years:3%
3 Years:2%
Last Year:4%

Last Updated: September 5, 2025, 1:26 pm

Balance Sheet

Last Updated: December 4, 2025, 1:57 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 788888889991010
Reserves 3895396399791,0771,1891,3211,4711,8141,7751,8002,3622,427
Borrowings 118189221241191194390846683798937588593
Other Liabilities 163169194244223218270308370323347351465
Total Liabilities 6789051,0621,4721,4991,6101,9892,6322,8762,9043,0933,3113,495
Fixed Assets 2943165804925345586501,1111,3421,3681,3851,4181,801
CWIP 11122295141210429666541506655719822534
Investments 106653253140210213443403532
Other Assets 2623013345876156216629599938389501,0371,128
Total Assets 6789051,0621,4721,4991,6101,9892,6322,8762,9043,0933,3113,495

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 7069129374514712447105180137132
Cash from Investing Activity + -49-196-106-257-10-196-290-404-286-232-171-198
Cash from Financing Activity + -28136-20313-611017643683464763
Net Cash Flow -89393-26-391079-98-713-3
Free Cash Flow -36-7412-79-92-151-220-302-226-46-48-111
CFO/OP 79%73%103%43%55%123%76%52%69%215%74%57%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-2.00-60.00-68.00-76.00-36.00-46.00-171.00-665.00-481.00-699.00-698.00-272.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 434843801021019988124113125126
Inventory Days 143147161187194266298427338280309309
Days Payable 108851011101061151229113912515685
Cash Conversion Cycle 79111104157189253275425323268278350
Working Capital Days 303327799898687277-134881
ROCE %20%18%16%14%10%9%12%8%6%1%5%8%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 50.01%50.01%50.01%50.01%50.01%44.39%44.33%44.23%44.23%44.23%44.23%40.13%
FIIs 13.73%10.26%8.60%8.52%5.63%9.08%9.59%9.90%10.97%11.19%10.92%10.97%
DIIs 0.54%0.37%0.41%0.06%1.65%7.61%8.18%8.27%7.55%7.46%7.67%8.34%
Public 35.72%39.36%40.98%41.41%42.71%38.91%37.90%37.59%37.25%37.10%37.18%40.56%
No. of Shareholders 46,86950,43444,09443,63046,04641,07242,78449,03450,10848,63652,06553,799

Shareholding Pattern Chart

No. of Shareholders

Shilpa Medicare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Bandhan Small Cap Fund 2,527,968 0.42 85.12,497,9682026-03-23 02:51:241.2%
ICICI Prudential ELSS Tax Saver Fund 2,065,936 0.48 69.55N/AN/AN/A
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 1,959,531 0.97 65.971,926,2982026-02-23 01:13:481.73%
Aditya Birla Sun Life Pharma & Healthcare Fund 556,964 2.2 18.75486,9642026-02-23 01:13:4814.37%
Aditya Birla Sun Life Small Cap Fund 554,077 0.38 18.65447,1982026-03-12 05:48:2723.9%
ICICI Prudential Exports and Services Fund 352,687 0.86 11.87445,1072026-03-23 02:51:24-20.76%
Aditya Birla Sun Life Manufacturing Equity Fund 314,865 0.96 10.6284,2272026-02-23 01:13:4810.78%
WhiteOak Capital Mid Cap Fund 292,082 0.21 9.83N/AN/AN/A
Aditya Birla Sun Life Retirement Fund - The 30s Plan 185,970 1.48 6.2679,1002026-01-25 01:15:46135.11%
ITI Pharma and Healthcare Fund 49,568 0.75 1.67N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 0.043.67-3.747.2618.13
Diluted EPS (Rs.) 0.043.67-3.747.2618.13
Cash EPS (Rs.) 19.6916.667.8816.5924.77
Book Value[Excl.RevalReserv]/Share (Rs.) 242.58208.37204.41208.65180.00
Book Value[Incl.RevalReserv]/Share (Rs.) 242.58208.37204.41208.65180.00
Revenue From Operations / Share (Rs.) 131.55132.67120.98131.97110.53
PBDIT / Share (Rs.) 34.7929.1113.7925.1325.98
PBIT / Share (Rs.) 23.2316.682.7915.9319.36
PBT / Share (Rs.) 12.646.81-3.9712.2024.14
Net Profit / Share (Rs.) 8.144.23-3.127.4018.15
NP After MI And SOA / Share (Rs.) 8.013.67-3.746.9918.13
PBDIT Margin (%) 26.4421.9411.3919.0323.50
PBIT Margin (%) 17.6612.572.3012.0717.51
PBT Margin (%) 9.605.13-3.289.2421.83
Net Profit Margin (%) 6.183.18-2.585.6016.41
NP After MI And SOA Margin (%) 6.082.76-3.095.2916.39
Return on Networth / Equity (%) 3.301.76-1.823.329.99
Return on Capital Employeed (%) 8.616.031.146.107.75
Return On Assets (%) 2.361.03-1.112.105.60
Long Term Debt / Equity (X) 0.090.300.160.190.32
Total Debt / Equity (X) 0.240.510.440.370.48
Asset Turnover Ratio (%) 0.400.380.360.120.36
Current Ratio (X) 1.461.260.981.451.52
Quick Ratio (X) 0.940.760.570.860.99
Inventory Turnover Ratio (X) 3.711.281.100.351.16
Dividend Payout Ratio (NP) (%) 0.000.000.0014.780.00
Dividend Payout Ratio (CP) (%) 0.000.000.006.380.00
Earning Retention Ratio (%) 0.000.000.0085.220.00
Cash Earning Retention Ratio (%) 0.000.000.0093.620.00
Interest Coverage Ratio (X) 4.502.752.045.309.68
Interest Coverage Ratio (Post Tax) (X) 2.431.330.532.354.98
Enterprise Value (Cr.) 7032.844901.022756.044084.093310.97
EV / Net Operating Revenue (X) 5.474.262.623.573.67
EV / EBITDA (X) 20.6719.4023.0318.7315.63
MarketCap / Net Operating Revenue (X) 5.043.481.903.013.02
Retention Ratios (%) 0.000.000.0085.210.00
Price / BV (X) 2.732.211.121.891.84
Price / Net Operating Revenue (X) 5.043.481.903.013.02
EarningsYield 0.010.01-0.010.010.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 477.34 Cr. and Equity Capital is Rs. 9.78 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals12-6-214/A-1, Shilpa House, Raichur Karnataka 584135Contact not found
Management
NamePosition Held
Mr. Omprakash InaniChairman
Mr. Vishnukant C BhutadaManaging Director
Mr. Kalakota Sharath ReddyWhole Time Director
Mr. Hetal Madhukant GandhiIndependent Director
Dr. Anita BandyopadhyayIndependent Woman Director
Dr. Kamal K SharmaIndependent Director
Mr. Ashraf Loutfy Abdelhamid AllamAddnl. & Ind.Director

FAQ

What is the intrinsic value of Shilpa Medicare Ltd and is it undervalued?

As of 20 April 2026, Shilpa Medicare Ltd's intrinsic value is ₹150.54, which is 59.86% lower than the current market price of ₹375.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (4.21 %), book value (₹125), dividend yield (0.13 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Shilpa Medicare Ltd?

Shilpa Medicare Ltd is trading at ₹375.00 as of 20 April 2026, with a FY2026-2027 high of ₹502 and low of ₹260. The stock is currently in the middle of its 52-week range. Market cap stands at ₹7,328 Cr..

How does Shilpa Medicare Ltd's P/E ratio compare to its industry?

Shilpa Medicare Ltd has a P/E ratio of 41.4, which is below the industry average of 53.84. This is broadly in line with or below the industry average.

Is Shilpa Medicare Ltd financially healthy?

Key indicators for Shilpa Medicare Ltd: ROCE of 7.82 % is on the lower side compared to the industry average of 16.35%; ROE of 4.21 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.13 %.

Is Shilpa Medicare Ltd profitable and how is the profit trend?

Shilpa Medicare Ltd reported a net profit of ₹78 Cr in Mar 2025 on revenue of ₹1,281 Cr. Compared to ₹61 Cr in Mar 2022, the net profit shows an improving trend.

Does Shilpa Medicare Ltd pay dividends?

Shilpa Medicare Ltd has a dividend yield of 0.13 % at the current price of ₹375.00. The company pays dividends, though the yield is modest.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Shilpa Medicare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports